Medical innovation prizes instead of monopolies

A Greens/EFA Conference

recorded stream: from the European Parliament - Brussels

31 May 2011 - 09:30 to 13:00

Organised by Greens/EFA MEP Carl Schlyter

To follow this stream you need the Macromedia (Adobe) Flash plugin.
it can be downloaded here:

http://www.macromedia.com/go/getflash

Innovation Inducement Prizes that de-link the cost of R&D from the price of products to increase access to medicines for patients living in Europe and developing countries

PROGRAMME

09:30-09:45
Welcome

• Carl Schlyter, MEP
• James Love, Knowledge Ecology International

09:45-10:30
Introduction

• David Hammerstein, TransAtlantic Consumer Dialogue (TACD) What are Innovations inducement prizes?

• Tim Hubbard, Welcome Trust: The role of prizes to reward innovation and sharing of knowledge in health care technologies

10:30-11:30 
Panel 1: Prize Funds for poverty related diseases in developing countries

1. Michelle Childs, MSF: Prizes for TB diagnostics
2. Dwayne Spradin, InnoCentive: Experiences with prizes for global health challenges

Respondent: EU Commission

11:30-12:30
Panel 2:  Prize Funds for health challenges in developed countries

1. Michael Behan, Chief Counsel U.S. Senator Sanders: The proposals for a U.S. Medical Innovation Prize Fund and an Open Source Dividend. Prizes to transform drug development incentives and outcomes
2. James Love, Knowledge Ecology International: The use of innovation prizes to eliminate monopolies for cancer drugs in Europe
3. Glyn Moody, Innovation inducement prizes as a possible mechanism to unlock the benefits of open innovation models

Respondent: EU Commission: Benedikt Hermann, responsible for inducement prizes in the European Commission (confirmed)

12:30-13:00
Wrap Up discussions and Next Steps
Moderator: Carl Schlyter, MEP